ImmuCell Corporation (ICCC) Capital expenditures 2016–2025
ImmuCell Corporation (ICCC) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$1.3MFY2025 · since FY2016: $3.6M → $1.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.3M | +168.5% |
| FY2024 | $465,725 | -75.4% |
| FY2023 | $1.9M | -52.4% |
| FY2022 | $4.0M | +52.4% |
| FY2021 | $2.6M | -35.9% |
| FY2020 | $4.1M | +192.7% |
| FY2019 | $1.4M | -31.5% |
| FY2018 | $2.0M | -88.6% |
| FY2017 | $17.8M | +395.2% |
| FY2016 | $3.6M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice